Nunes A D C, Souza A P S, Macedo L M, Alves P H, Pedrino G R, Colugnati D B, Mendes E P, Santos R A S, Castro C H
Departamento de Ciências Fisiológicas, Universidade Federal de Goiás, Goiânia, GO, Brasil.
Instituto Nacional de Ciência e Tecnologia em Nanobiofarmacêutica, Brasil.
Braz J Med Biol Res. 2017 Mar 23;50(4):e5520. doi: 10.1590/1414-431X20165520.
This study investigated the influence of antihypertensive drugs, such as angiotensin-converting enzyme inhibitors (ACEIs), AT1 receptor blockers (ARBs), voltage-gated L-type calcium channel blockers, and mineralocorticoid receptor antagonists (MRAs), on the effects of angiotensin-(1-7) [Ang-(1-7)] on aorta and coronary arteries from pressure-overloaded rats. Pressure overload was induced by abdominal aortic banding (AB). To evaluate the role of antihypertensive drugs on the effect of Ang-(1-7), AB male Wistar rats weighing 250-300 g were treated with vehicle or low doses (5 mg·kg-1·day-1, gavage) of losartan, captopril, amlodipine, or spironolactone. Isolated aortic rings and isolated perfused hearts under constant flow were used to evaluate the effect of Ang-(1-7) in thoracic aorta and coronary arteries, respectively. Ang-(1-7) induced a significant relaxation in the aorta of sham animals, but this effect was reduced in the aortas of AB rats. Chronic treatments with losartan, captopril or amlodipine, but not with spironolactone, restored the Ang-(1-7)-induced aorta relaxation in AB rats. The coronary vasodilatation evoked by Ang-(1-7) in sham rats was blunted in hypertrophic rats. Only the treatment with losartan restored the coronary vasodilatory effect of Ang-(1-7) in AB rat hearts. These data support a beneficial vascular effect of an association of Ang-(1-7) and some antihypertensive drugs. Thus, this association may have potential as a new therapeutic strategy for cardiovascular diseases.
本研究调查了抗高血压药物,如血管紧张素转换酶抑制剂(ACEI)、AT1受体阻滞剂(ARB)、电压门控L型钙通道阻滞剂和盐皮质激素受体拮抗剂(MRA),对血管紧张素-(1-7)[Ang-(1-7)]对压力超负荷大鼠主动脉和冠状动脉作用的影响。通过腹主动脉缩窄(AB)诱导压力超负荷。为了评估抗高血压药物对Ang-(1-7)作用的影响,对体重250 - 300 g的AB雄性Wistar大鼠给予溶剂或低剂量(5 mg·kg-1·天-1,灌胃)的氯沙坦、卡托普利、氨氯地平或螺内酯。分别使用离体主动脉环和恒流条件下的离体灌注心脏来评估Ang-(1-7)对胸主动脉和冠状动脉的作用。Ang-(1-7)在假手术动物的主动脉中诱导显著舒张,但在AB大鼠的主动脉中这种作用减弱。氯沙坦、卡托普利或氨氯地平的慢性治疗可恢复AB大鼠中Ang-(1-7)诱导的主动脉舒张,而螺内酯则不能。Ang-(1-7)在假手术大鼠中引起的冠状动脉舒张在肥厚大鼠中减弱。只有氯沙坦治疗可恢复AB大鼠心脏中Ang-(1-7)的冠状动脉舒张作用。这些数据支持Ang-(1-7)与某些抗高血压药物联合使用具有有益的血管效应。因此,这种联合可能具有作为心血管疾病新治疗策略的潜力。